Anixa Biosciences Inc

Research Anixa Biosciences Inc (ANIX) on Bullrun: market cap USD 96.68M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerANIX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 96.68M
• Financial periodFY2025
• Net income-USD 10.93M

Valuation Snapshot

latest market cap is USD 96.68M.

About Anixa Biosciences Inc

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer;

Frequently asked questions

What is Anixa Biosciences Inc's market cap?

Anixa Biosciences Inc's market capitalization is USD 96.68M.

What does Anixa Biosciences Inc do?

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.